Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood–retinal barrier
✍ Scribed by Wiegand, S; Yancopoulos, G; Zack, D J; Campochiaro, P A; Nambu, H; Nambu, R; Oshima, Y; Hackett, S F; Okoye, G
- Book ID
- 110039523
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 455 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0969-7128
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Vascular endothelial growth factor (VEGF) plays a central role in the development of retinal neovascularization and diabetic macular edema. There is also evidence suggesting that VEGF is an important stimulator for choroidal neovascularization. In this study, we investigated the effect of a specific
## Abstract Breakdown of the blood‐retinal barrier (BRB) occurs in several retinal diseases and is a major cause of visual loss. Vascular endothelial growth factor (VEGF) has been implicated as a cause of BRB breakdown in diabetic retinopathy and other ischemic retinopathies, and there is evidence